摘要
立体定向放疗（SBRT）越来越广泛地应用于早期NSCLC的治疗,已成为无法耐受手术的早期NSCLC患者的标准治疗技术.相较于其他影像学方法,^18F-FDG PET/CT在NSCLC的诊断、分期和疗效预测中具有更高的准确性,其在SBRT疗效判断和预后预测方面的作用也日益得到重视,笔者就该领域的研究进展做一综述.
Stereotactic body radiation therapy （SBRT） has been increasingly used in the treatment of early-stage NSCLC,especially for patients who cannot undergo surgery.Compared with other imaging modalities,PET/CT has higher sensitivity and specificity in diagnosis and staging of NSCLC as well as higher prediction value for prognosis.The progress of ^18F-FDG PET/CT in evaluation of the therapeutic response and prognosis after SBRT for early-stage NSCLC is summarized in this review.
出处
《中华核医学与分子影像杂志》
北大核心
2015年第2期157-160,共4页
Chinese Journal of Nuclear Medicine and Molecular Imaging
